TimeTeller joins the capacura family!
We’re thrilled to announce that TimeTeller is now officially part of the capacura portfolio — marking the next step in our mission to bring cancer therapy in sync with each patient’s inner clock.
Many chemotherapy treatments lose effectiveness simply because they are administered at the wrong time of day.
That’s where TimeTeller comes in:
With a saliva-based diagnostic test, we determine each patient’s individual circadian rhythm to identify the optimal time for drug administration.
The result:
➤ fewer side effects
➤ fewer treatment interruptions
➤ higher efficacy
Our vision is to bring chronomedicine from research to real-world clinical application — scientifically grounded, technologically robust, and focused on measurable patient benefit.
Together with capacura and partners such as Charité and Techniker Krankenkasse, we aim to pave the way for a new era of personalized cancer therapy.
As of today, TimeTeller is also open for public investment — for everyone who believes in the power of the body’s inner clock.